200 related articles for article (PubMed ID: 19526239)
21. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
22. Immobilized MHC class I chain-related protein A synergizes with IL-15 and soluble 4-1BB ligand to expand NK cells with high cytotoxicity ex vivo.
Gong W; Xiao W; Qian L; Gong C; Hu M; Pan X; Ji M
Cell Mol Immunol; 2010 Nov; 7(6):477-84. PubMed ID: 20871627
[TBL] [Abstract][Full Text] [Related]
23. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
[TBL] [Abstract][Full Text] [Related]
24. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
de Rham C; Ferrari-Lacraz S; Jendly S; Schneiter G; Dayer JM; Villard J
Arthritis Res Ther; 2007; 9(6):R125. PubMed ID: 18053164
[TBL] [Abstract][Full Text] [Related]
25. Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Vasu S; He S; Cheney C; Gopalakrishnan B; Mani R; Lozanski G; Mo X; Groh V; Whitman SP; Konopitzky R; Kössl C; Bucci D; Lucas DM; Yu J; Caligiuri MA; Blum W; Adam PJ; Borges E; Rueter B; Heider KH; Marcucci G; Muthusamy N
Blood; 2016 Jun; 127(23):2879-89. PubMed ID: 27013443
[TBL] [Abstract][Full Text] [Related]
26. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
Sanchez-Correa B; Morgado S; Gayoso I; Bergua JM; Casado JG; Arcos MJ; Bengochea ML; Duran E; Solana R; Tarazona R
Cancer Immunol Immunother; 2011 Aug; 60(8):1195-205. PubMed ID: 21644031
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
30. Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors.
Oberholtzer E; Contarini M; Veglia F; Cossarizza A; Franceschi C; Geuna M; Provinciali M; Di Stefano G; Sissom J; Brizzi MF; Pegoraro L; Matera L
Adv Neuroimmunol; 1996; 6(3):233-47. PubMed ID: 8968423
[TBL] [Abstract][Full Text] [Related]
31. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
Törnroos H; Hägerstrand H; Lindqvist C
Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
[TBL] [Abstract][Full Text] [Related]
32. IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells.
Park JY; Lee SH; Yoon SR; Park YJ; Jung H; Kim TD; Choi I
Mol Cells; 2011 Sep; 32(3):265-72. PubMed ID: 21809216
[TBL] [Abstract][Full Text] [Related]
33. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
34. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
[TBL] [Abstract][Full Text] [Related]
35. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
[TBL] [Abstract][Full Text] [Related]
36. NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
Brune M; Hansson M; Mellqvist UH; Hermodsson S; Hellstrand K
Eur J Haematol; 1996 Oct; 57(4):312-9. PubMed ID: 8982295
[TBL] [Abstract][Full Text] [Related]
37. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.
Costello RT; Sivori S; Marcenaro E; Lafage-Pochitaloff M; Mozziconacci MJ; Reviron D; Gastaut JA; Pende D; Olive D; Moretta A
Blood; 2002 May; 99(10):3661-7. PubMed ID: 11986221
[TBL] [Abstract][Full Text] [Related]
38. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
40. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.
Biswas BK; Guru SA; Sumi MP; Jamatia E; Gupta RK; Lali P; Konar BC; Saxena A; Mir R
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1595-1605. PubMed ID: 32592353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
